Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
atigotatug/nivolumab (BMS-986489) - BMS
http://clinicaltrials.gov/ct2/show/NCT06773910
Sep 22, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next